NIH Clinical Trial Integrity Act

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 3564 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 3564 To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES December 18, 2025 Mr. Kim (for himself and Ms. Collins) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``NIH Clinical Trial Integrity Act''. SEC. 2. DIVERSITY GOALS FOR CLINICAL TRIALS FUNDED BY THE …